Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAs”) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer

Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAs”) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer

US Patent 8354093 · Granted Jan 15, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleotide derivatives and methods of use thereof2025
Synthesis and characterization of well defined poly(propylene fumarate) and poly2025
Quantitative analysis of proteins2025
Self-assembling oxygen carrier compositions2025
Poly(propylene fumarate)-based copolymers for 3D printing applications2025
Cleavable tetrazine used in bio-orthogonal drug activation2025
Block copolymers of lactones and poly(propylene fumarate)2025
Nucleotide analogues and use thereof for nucleic acid sequencing and analysis pr2025
Compositions and methods for removing bio-synthetic nano-particles from bodily f2024
Synthesis of Mg(BHT)2(THF)22024
3′-O-modified nucleotide analogues with different cleavable linkers for attachin2024
Synthesis of novel disulfide linker based nucleotides as reversible terminators 2024